News & Articles

Kit increases efficiency of residual protein A ligand detection

Advancing immunology research for a healthier world

Expansion of TxCell’s CAR-Treg platform to develop novel proprietary population of CD8+ regulatory T cells

Use of cell imaging technology enables cutting-edge research into the assessment of bioactive compounds in cell lines

Fully scalable system streamlines drug development and production with sizes ranging from 3-liter bench-top to 1000-liter manufacturing scale

UMassMedNow, UMass Medical School’s news service, reports how Jeremy Luban, MD and Scot Wolfe PhD are exploring the novel CRISPR/Cpf1 technique

AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure

Discover why recombinantly engineered REAfinity Antibodies offer improved consistency, reproducibility and purity over traditionally produced monoclonal antibodies

Enhanced biomolecular characterization platform expands assay capabilities for biologics and small molecule characterization, increasing data access and quality